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Abstract Burkholderia phage AP3 (vB_BceM_AP3) is a
temperate virus of the Myoviridae and the Peduovirinae sub-
family (P2likevirus genus). This phage specifically infects
multidrug-resistant clinical Burkholderia cenocepacia lineage
IIIA strains commonly isolated from cystic fibrosis patients.
AP3 exhibits high pairwise nucleotide identity (61.7 %) to
Burkholder ia phage KS5, spec i f i c to the same
B. cenocepacia host, and has 46.7–49.5 % identity to phages
infecting other species of Burkholderia. The lysis cassette of
these related phages has a similar organization (putative
antiholin, putative holin, endolysin, and spanins) and shows
29–98 % homology between specific lysis genes, in contrast
to Enterobacteria phage P2, the hallmark phage of this genus.
The AP3 and KS5 lysis genes have conserved locations and
high amino acid sequence similarity. The AP3 bacteriophage
particles remain infective up to 5 h at pH 4–10 and are stable at
60 °C for 30 min, but are sensitive to chloroform, with no
remaining infective particles after 24 h of treatment. AP3 ly-
sogeny can occur by stable genomic integration and by pseu-
do-lysogeny. The lysogenic bacterial mutants did not exhibit
any significant changes in virulence compared to wild-type
host strain when tested in the Galleria mellonella moth wax
model. Moreover, AP3 treatment of larvae infected with
B. cenocepacia revealed a significant increase (P < 0.0001)
in larvae survival in comparison to AP3-untreated infected
larvae. AP3 showed robust lytic activity, as evidenced by its
broad host range, the absence of increased virulence in lyso-
genic isolates, the lack of bacterial gene disruption condi-
tioned by bacterial tRNA downstream integration site, and
the absence of detected toxin sequences. These data suggest
that the AP3 phage is a promising potent agent against bacte-
ria belonging to the most common B. cenocepacia IIIA line-
age strains.
Keywords Temperate phage .Peduovirinae .Burkholderia
cepacia lineage IIIA
Introduction
Gram-negative, non-fermentative bacilli of the Burkholderia
cepacia complex (BCC) are inherently difficult to eradicate
clinically. They are dangerous opportunistic pathogens that
infect patients suffering from cystic fibrosis (CF). The BCC
includes 17 closely related bacterial species (B. cepacia,
Burkholderia multivorans, Burkholderia cenocepacia,
Burkholderia stabilis, Burkholderia vietnamiensis,
Burkholderia dolosa, Burkholderia ambifaria, Burkholderia
anthina, Burkholderia pyrrocinia, Burkholderia ubonensis,
Burkholderia latens, Burkholderia diffusa, Burkholderia
arboris, Burkholderia seminalis, Burkholderia metallica,
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Burkholderia contaminans, and Burkholderia lata), which
can only be discriminated from each other using molecular
methods (Drevinek and Mahenthiralingam 2010; Medina-
Pascual et al. 2012). The BCC bacteria survive for long pe-
riods in moist environments and can cause hospital outbreaks
especially in immunocompromised patients; they also con-
taminate pharmaceutical products and water supplies
(Gilligan et al. 2003). The most prevalent isolates in CF pa-
tients, B. multivorans and B. cenocepacia, are responsible for
85–97 % of infections (Drevinek and Mahenthiralingam
2010). B. cenocepacia also infects patients suffering from
chronic granulomatous disease (CGD; Bylund et al. 2005).
Lung infection of CF patients by BCC leads to Bcepacia
syndrome,^ an acute, necrotizing pneumonia leading to death
(Isles et al. 1984). Based on recA gene polymorphisms,
B. cenocepacia isolates can be subdivided into four lineages.
Lineages IIIA–D and IIIA/IIID are exclusively found in clin-
ical samples, IIIC occurs only in soil, and IIIB occurs in both
environmental and clinical samples (Mahenthiralingam et al.
2000; Vandamme et al. 2003; Manno et al. 2004).
B. cenocepacia has multiple virulence factors, including
cepacian exopolysaccharide (crucial for chronic infections),
adhesins, pili and flagella, biofilm, and type III and IV secre-
tion systems, recently reviewed in detail (Leitão et al. 2010;
Casey and McClean 2015). The B. cenocepacia genome in-
cludes large, horizontally transferred genomic islands span-
ning up to 9.3 % of the chromosome, which are considered
to be important in adaptation to different environments
(Holden et al. 2009).
Bacteriophages have been proposed as effective antibacte-
rial agents to eradicate bacterial pathogens (Hyman and
Abedon 2010; Abedon 2011; Drulis-Kawa et al. 2012 and
2015). Treatment with bacteriophages allows targeting patho-
gens that are resistant to conventional drugs without damaging
the host’s natural flora. The efficacy of bacteriophages against
CF pathogens has been shown in vivo using the Galleria
mellonella insect model and various mouse pulmonary infec-
tion models (Seed and Dennis 2009; Carmody et al. 2010;
Lynch et al. 2010; Saussereau et al. 2014; Olszak et al.
2015; Danis-Włodarczyk et al. 2016). The synergistic effect
of combining bacterial viruses with antibiotics may lead to
higher production of phage progeny and increased phage ac-
tivity, improving bacterial killing (Kamal and Dennis 2015).
Phage-based treatment poses some risks and limitations;
therefore, a principle requirement is phage precise characteri-
zation not only in terms of biology, but also in genomic as-
pects (Merril et al. 2003; Drulis-Kawa et al. 2012 and 2015).
There are reports that reinforce the idea of possible temperate
phage application with approaches in using them for bacterial
virulence modification. The lysogenization process of temper-
ate Pseudomonas phages DMS3, MP22, and D3112 caused
the inhibition in the expression of virulence factors, including
bacterial group motility (swarming and twitching motility) or
biofilm formation, leading to significant decrease in the mor-
tality of Pseudomonas-infected animals. The changes in bac-
terial pathogenicity after phage integration into bacterial ge-
nome can be explained by host gene disruption, CRISPR/Cas
system interaction, or by mechanisms independent of the host
background (Chung et al. 2012; Zegans et al. 2009; Cady et al.
2012; Drulis-Kawa et al. 2015).
To date, 37 Burkholderia specific phages have been depos-
ited into GenBank (status on 28.06.2016), including members
of the Myoviridae (18), Siphoviridae (9), and Podoviridae
(10) families. The presence of a recombinase or integrase in
the bacteriophage genome, indicating the temperate nature of
the phage (Gill and Young 2011), was confirmed for 22 of
these 37 sequenced genomes (phiE202, phi52237, KS14,
KL3, KS5, BEK, and φX216 from Myovir idae ,
Peduovirinae, and P2likevirus; AH2, KL1, Bcep176,
Phi1026b, phiE125, and KS9 from Siphoviridae; and
BcepMigl, DC1, BcepC6B, BcepIL02, Bcep22 Bp-AMP1,
Bp-AMP2, Bp-AMP3, and Bp-AMP4 from Podoviridae).
Also several other viruses including Enterobacteria phages:
P2, 186, PsP3, and Wφ; Yersinia phage L-413C; Salmonella
phages Fels-2 and SopEφ; Pseudomonas phage φCTX;
Mannheimia phageφ-MhaA1_PHL101; and Ralstonia phage
RSA1 belong to the P2likevirus genus (Lavigne et al. 2009).
Even though these phages were classified as temperate, they
could be engineered as lytic mutants (Lynch et al. 2010) or
provide a source for proteins (e.g., endolysins and
depolymerases), which could potentially be used as enzyme-
based antibacterials. Here, we report a newly discovered
B. cenocepacia IIIA-specific temperate phage, designated
AP3 (vB_BceM_AP3), and classified to the P2likevirus ge-
nus. This phage was characterized in terms of genome orga-
nization including lysis cassette, the integration site and lysog-
eny event analysis, and the tail fiber protein amino acids com-
position with the other P2-like phages and prophages found in
host sequences. Furthermore, the efficacy of AP3 in the erad-
ication of B. cenocepacia infection in moth larvae and the
emergence of resistant clones was studied.
Materials and methods
Phage isolation and propagation
Phage AP3 was isolated from a natural wastewater treatment
plant (irrigated fields) in Wroclaw (Poland) as previously de-
scribed (Olszak et al. 2015). AP3 was isolated from and prop-
agated in the clinical isolate 7780 of B. cenocepacia IIIA
lineage (Table 1). The titer and plaque morphology were
assessed by the double-agar layer technique (Adams 1959).
The B. cenocepacia isolate 7780 has been deposited in Polish
Collection of Microorganisms under accession no. PCM
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Table 1 AP3 phage activity on the collection of BCC strains
No. Isolate no. BCC strains Origin AP3 phage
10^5 pfu/ml
AP3 phage
10^8 pfu/ml
1 5 B. cenocepacia lineage IIIA Lung transplant—Freeman Hospital, Newcastle, UK + +
2 6 B. cenocepacia lineage IIIA Lung transplant—Freeman Hospital, Newcastle, UK + +
3 10 B. cenocepacia lineage IIIA Lung transplant—Freeman Hospital, Newcastle, UK + +
4 18 B. cenocepacia lineage IIIA Lung transplant—Freeman Hospital, Newcastle, UK + +
5 19 B. cenocepacia lineage IIIA Lung transplant—Freeman Hospital, Newcastle, UK − −
6 20 B. cenocepacia lineage IIIA Lung transplant—Freeman Hospital, Newcastle, UK + +
7 21 B. cenocepacia lineage IIIA Lung transplant—Freeman Hospital, Newcastle, UK + +
8 7780 B. cenocepacia lineage IIIA Lung transplant—Freeman Hospital, Newcastle, UK + +
9 1567 B. cenocepacia lineage IIIA Queen’s University of Belfast, UK + +
10 1571 B. cenocepacia lineage IIIA Queen’s University of Belfast, UK − −
11 1921 B. cenocepacia lineage IIIA Queen’s University of Belfast, UK − −
12 1945 B. cenocepacia lineage IIIA Queen’s University of Belfast, UK − −
13 1946 B. cenocepacia lineage IIIA Queen’s University of Belfast, UK − −
14 1947 B. cenocepacia lineage IIIA Queen’s University of Belfast, UK + +
15 30 B. cenocepacia lineage IIIA Royal Victoria Infirmary, Newcastle, UK − −
16 39 B. cenocepacia lineage IIIA Royal Victoria Infirmary, Newcastle, UK + +
17 45 B. cenocepacia lineage IIIB Royal Victoria Infirmary, Newcastle, UK − −
18 1 B. cenocepacia lineage IIIE Lung transplant—Freeman Hospital, Newcastle, UK − −
19 35 B. cenocepacia lineage IIIE Royal Victoria Infirmary, Newcastle, UK − −
20 14 B. cenocepacia lineage non-IIIA/IIIB Lung transplant—Freeman Hospital, Newcastle, UK − −
21 2 B. cepacia group 6 Lung transplant—Freeman Hospital, Newcastle, UK − −
22 3830 B. contaminans Queen’s University of Belfast, UK − −
23 3831 B. contaminans Queen’s University of Belfast, UK − −
24 3832 B. contaminans Queen’s University of Belfast, UK − −
25 3833 B. contaminans Queen’s University of Belfast, UK − −
26 44 B. contaminans Royal Victoria Infirmary, Newcastle, UK − −
27 34 B. multivorans Southern Ireland, UK − −
28 3 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
29 4 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
30 7 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
31 9 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
32 11 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
33 12 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
34 13 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
35 17 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
36 22 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
37 23 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
38 28 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
39 31 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
40 33 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
41 38 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
42 41 B. multivorans Lung transplant—Freeman Hospital, Newcastle, UK − −
43 24 B. multivorans Lung transplant—Queensland, UK − −
44 25 B. multivorans Lung transplant—Queensland, UK − −
45 1566 B. multivorans Queen’s University of Belfast, UK − −
46 1568 B. multivorans Queen’s University of Belfast, UK − −
47 1572 B. multivorans Queen’s University of Belfast, UK − −
48 1573 B. multivorans Queen’s University of Belfast, UK − −
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2854. The phage AP3 is available in the collection of Institute
of Genetics and Microbiology, Wroclaw, Poland.
Transmission electron microscopy (TEM)
A filtered high-titer phage lysate was centrifuged at 25,000×g
for 60min. The pellet was washed twice in ammonium acetate
(0.1 M, pH 7.0). Phages were deposited on copper grids with
carbon-coated Formvar films (Sigma-Aldrich Co., St. Louis,
MO, USA) and stained for 10 s with uranyl acetate (2 %,
pH 4.5). Excess liquid was blotted off and phages were exam-
ined using a Zeiss EM 900 electron microscope (Carl Zeiss
Microscopy GmbH, Jena, Germany) at the Laboratory of
Microscopy Techniques, University of Wroclaw, Poland.
The magnification was calibrated using T4 phage tail length
(114 nm) as a standard.
DNA isolation, purification, and sequencing
Phage DNA isolation was performed with the modified pro-
tocol for λ DNA isolation (Sambrook and Russell 2001) from
purified phage particles (108 pfu/ml). The phage AP3 genome
was sequenced using an Illumina MiSeq platform available at
the Department of Applied Sciences, University of
Northumbria (UK). A quality filtering, assembly, and draft
genome was applied using CLC genomics workbench v. 7.5
(CLC Bio, Aarhus, Denmark). Low quality reads (<0.05),
reads with two or more ambiguities, and reads shorter than
100 bpwere removed. After trimming and filtering, there were
476,529,248 bp from 2,042,560 reads with an average length
of 233.3 bp. The processed reads were used for reference
genome assembly with Burkholderia phage KS5 (GenBank
accession number GU911303) used as reference and de novo
assembly, yielding 2016 contigs with an average contig size of
3836 bp; the N50 contig size was 6333 bp with the largest
contig 16,375 bp. A high-quality draft genomewas assembled
by closing the gaps between the scaffolded contigs of the
reference assembly by contig stitching with de novo contigs.
The final draft genome comprised one scaffold, counting for a
length of 36,499 bp, with an average coverage of 5639-fold.
The draft genome has an average GC content of 64.04 %.
Genome annotation and in silico analysis
The start of the AP3 genome was inferred by a location of the
left cos site, while the genes were oriented based on the com-
parison to the type phage of the P2likevirus (Enterobacteria
phage P2, GenBank accession number: NC_001895) and
three other similar P2-like phages found in the NCBI data-
base: φE202 (GenBank accession number: CP000623),
φX216 (GenBank accession number: JX681814), and
φ52237 (GenBank accession number: NC_007145). Even
though three other P2-like Burkholderia phages were used in
further analysis, onlyφE202, φX216, and φ52237 start with
the portal vertex protein, as the type species P2-like
Enterobacteria phage P2, which was used as the main genome
template. Open reading frames (ORFs) were predicted with
GeneMarkS and verified in following steps of annotation
(Besemer et al. 2001). The annotation of the AP3 genome
was performed using Artemis (Rutherford et al. 2000).
Protein domains and the search for proteins with a similar
structure were investigated with HMMER (Finn et al. 2011).
ORFs were compared with existing data stored in the NCBI
database, using BLASTN and BLASTP (Altschul et al. 1990;
Gish and States 1993). Further, TBLASTXwas used to search
for conserved protein coding sequences, not previously
Table 1 (continued)
No. Isolate no. BCC strains Origin AP3 phage
10^5 pfu/ml
AP3 phage
10^8 pfu/ml
49 1575 B. multivorans Queen’s University of Belfast, UK − −
50 26 B. multivorans Royal Victoria Infirmary, Newcastle, UK − −
51 27 B. multivorans Royal Victoria Infirmary, Newcastle, UK − −
52 29 B. multivorans Royal Victoria Infirmary, Newcastle, UK − −
53 32 B. multivorans Royal Victoria Infirmary, Newcastle, UK − −
54 36 B. multivorans-1 Lung transplant—Queensland, UK − −
55 37 B. multivorans-2 Lung transplant—Queensland, UK − −
56 42 B. seminalis Glasgow, Scotland, UK − −
57 40 B. stabilis Southern Ireland, UK − −
58 43 B. stabilis Lung transplant—Freeman Hospital, Newcastle, UK − −
59 8 B. vietnamiensis Lung transplant—Freeman Hospital, Newcastle, UK − −
60 15 B. vietnamiensis Lung transplant—Freeman Hospital, Newcastle, UK − −
61 16 B. vietnamiensis Lung transplant—Freeman Hospital, Newcastle, UK − −
+ active, − no activity
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annotated. Proteins with the highest BLAST bit score were
noted for each open reading frame, along with available
known domains. Search for possible transfer RNAs was done
using tRNAscan-SE and Aragorn (Schattner et al. 2005;
Laslett and Cänback 2004). Putative Rho-independent termi-
nators were investigated with ARNold (Gautheret and
Lambert 2001). The 100-nt sequences upstream from each
putative ORF were extracted via STORM to create input data
for repetitive motifs identification (Lavigne et al. 2003).
MEME was used to find conserved motifs in the genome
(Bailey et al. 2009) followed by manual verification of each
motif. The AP3 genome organization was visualized in Circos
(v. 0.67, Canada’s Michael Smith Genome Sciences Centre).
The genome of bacteriophage AP3 was deposited in the
GenBank under accession number KP966108.
To confirm the taxonomic cluster of AP3 as a novel phage,
nucleotide comparison of genomes of different species among
P2likevirus genus were made with CoreGenes 3.5 (Turner
et al. 2013) using a gene similarity setting to at least 80 %.
Phages used for comparison included BCC viruses, which
query cover identity was at least 85 %—KS5 (accession:
GU911303), KL3 (accession: GU911304), φE202 (acces-
sion: CP000623), BEK (accession: CP008753), φX216 (ac-
cession: JX681814), and φ52237 (accession DQ087285).
Data for the linear genome visualization was acquired using
TBLASTX (Altschul et al. 1990) and included in EasyFig 2.1
(Sullivan et al. 2011).
Identification and in silico analysis of the lysis proteins and
lysis cassette in the AP3 genome and selected BCC phages
was performed by protein and nucleotide BLAST analysis
(Altschul et al. 1990), HMMER (Finn et al. 2011),
HMMTOP, TMHMM (Bernsel et al. 2009), and the ExPASy
SIB Bioinformatics Resource Portal (Krogh et al. 2001). The
amino acid sequence similarity of individual lysis proteins
between AP3, Enterobacteria P2, and selected BCC P2-like
viruses was prepared in Circos (v. 0.67, Canada’s Michael
Smith Genome Sciences Centre).
Burst size experiments and sensitivity of phage particles
to temperature, chloroform, and pH
A one-step growth curve of the isolated Burkholderia phage
was performed as described (Pajunen et al. 2000) with some
modifications (Kesik-Szeloch et al. 2013). The sensitivity of
phage particles to temperature, chloroform, and pH was eval-
uated as previously described (Eriksson et al. 2015). Purified
viruses (Szermer-Olearnik and Boratyński 2015) were
suspended in phosphate-buffered saline (PBS). An equal vol-
ume of filter-sterilized bacteriophage containing 108 plaque-
forming units per milliliter (pfu/ml) was mixed with chloro-
form and incubated for 2 and 24 h at room temperature (RT),
with intermittent shaking. To establish the visions’ stability at
different pH values, a phage suspension of 108 pfu/ml was
diluted 10-fold in citric acid-Na2HPO4 buffer solution at
pH 2, 4, 5, 6, and 8 and sodium carbonate-sodium bicarbonate
buffer solutions at pH 10 and incubated for 1 or 5 h at RT.
Phage samples were also incubated at 60, 70, and 80 °C for 10
and 30 min. Phage titers were assessed using the soft agar
overlay method (Adams 1959; Kutter 2009). Phage particles
in PBS (pH 7.4) were used as a control in all the previously
described tests.
Determination of host range
The host specificity of AP3 phage was determined by spot
testing applying 105 and 108 pfu/ml (Kutter 2009) on 61
BCC clinical isolates (Table 1). Type IIIA and IIIB lineages
among B. cenocepacia strains were identified by PCR
(Mahenthiralingam et al. 2000). Sense and antisense primers
5 ′-GCTCGACGTTCAATATGCC-3 ′ and 5 ′-TCGA
GACGCACCGACGAG-3′ were used for IIIA detection (an-
nealing temperature 62 °C; expected product size 378 bp) and
primers 5′-GCTGCAAGTCATCGCTGAA-3′ and 5′-TACG
CCATCGGGCATGCT-3′ were used for IIIB detection (an-
nealing temperature 60 °C; expected product size 781 bp).
Pulsed-field gel electrophoresis (PFGE) was employed to dis-
criminate the clonal origin of B. cenocepacia IIIA isolates
sensitive to AP3 infection. PFGE was carried out according
to Chua et al. (2011) using a one-step lysis procedure in which
bacterial cells, immobilized in an agarose gel, were lysed in
lysis buffer containing 50 mM Tris, 50 mM EDTA, 1 % SDS,
and 100 μg/ml proteinase K (pH 8.0) at 56 °C for 2 h. Next,
agarose plugs were thoroughly rinsed with TE buffer (10 mM
Tris, 1 mM EDTA, pH 8.0) and digested with XbaI (Thermo
Fisher Scientific, Fermentas Life Science, Waltham, MA,
USA). DNA fragments were separated by PFGE on a CHEF
DRII apparatus (Bio-Rad Laboratories, Hemel Hempstead,
UK) in a 1 % agarose gel in 0.5 × TBE buffer at 12 °C. A
linear ramp of 5 to 65 s was used, and gels were run for 20 h at
200 V. MidRange PFGE Marker (New England Biolabs) was
used as a mass marker. DNAwas stained with ethidium bro-
mide. Bacteria were stored at −70 °C in trypticase soy broth
(TSB; Becton Dickinson and Company, Cockeysville, MD,
USA) supplemented with 20 % glycerol (Avantor
Performance Materials Poland S.A., Gliwice, Poland).
The emergence of phage-resistant clones
The B. cenocepacia 7780 host strain was cultured in 5 ml of
TSB (Becton Dickinson and Company, Cockeysville, MD,
USA) at 37 °C for 3 h to 108 cfu/ml. One hundred microliters
of AP3 phage (107 pfu/ml) was added to the bacterial culture
and incubated at 37 °C during 24 h. The surviving bacterial
cells were obtained by plating on TSA plates (Becton
Dickinson and Company, Cockeysville, MD, USA). Twenty
randomly isolated colonies were picked for further analysis
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and examined for AP3 sensitivity by spot testing, applying
either 107 or 105 pfu/ml to visualize individual plaques
(Kutter 2009). BCC resistance to phage infection was consid-
ered as possible lysogeny by AP3 temperate phage during the
bacterial culture infection. The presence of the AP3 genome
within the bacterial cell was confirmed by PCR according to
Kvitko et al . (2012). First , the unique AP3 gene
vB_BceM_AP3_0002 encoding cytotoxic translational re-
pressor of toxin-antitoxin stability systemwas chosen for con-
firmation of AP3 genome presence inside the host cell (F: 5′-
ATGAACTCGATCAAATGGACCCC-3′; R: 5′-TTAG
TACGTGCGTTCATCGCGTTTC-3′; annealing temperature
57 °C; expected product size 254 bp). Second, the phage in-
tegration next to the bacterial tRNA gene was determined to
match attR and attL sites, respectively (F: 5′-GCGC
CCGTAGCTCAATGG-3′; R: 5′-TCAGACGTCGAGCT
GCGCG-3′; annealing temperature 57 °C; expected product
size 806 bp). The episome form of AP3 was confirmed by the
detection of the intact integrase gene vB_BceM_AP3_0051
(F: 5′-ATGTCGCTCTATAAACGCAGTAACAGTCCC-3′;
R: 5′-TCAGCCGGCGGCGACGTGCAG-3′; annealing tem-
perature 57 °C; expected product size 1076 bp).
G. mellonella larvae infection model
TheG. mellonella infection model, performed as described by
Cullen et al. (2015), was used to assess the virulence of select-
ed isolates. Briefly, fresh bacterial cultures in LB broth were
diluted serially in saline solution to densities ranging between
106 and 108 cfu/ml. Each dilution was injected (10 μl) into the
hindmost proleg of healthy larvae (20 per group). Bacterial
burden was determined by plating 10 μl of the serial dilutions
onto LB agar and colonies were counted after 24 h. The
injected larvae were incubated at 37 °C for 24 h; the numbers
of dead larvae were counted and the LD50 values determined
and presented as a mean (N = 3 experiments). The in vivo
phage treatment assay was conducted on a wax moth larvae
model as described previously (Olszak et al. 2015). To assess
the antibacterial activity of AP3, larvae (N = 60) were sequen-
tially injected with a 10-μl lethal dose of 105 cells of
B. cenocepacia 7780 host strain and 10 μl of phage lysate at
the titration equal to multiplicity of infection (MOI) 10. After
injection into the ventral side, the larvae were incubated for
72 h at 37 °C and the results were expressed as the percentage
survival rate assessed by the lack of touch-provoked motility
and the appearance of pigmentation at 18, 24, 36, 48, and 72 h
post-injection. Experiments were performed six times (10 lar-
vae per trial). The controls consisted of uninfected and larvae
receiving phage lysate only or saline solution (negative) and
infected with bacterial lethal dose (positive; N = 10 per each
probe). The analysis of survival curves was performed by the
log-rank Mantel–Cox test using GraphPad Prism software
(GraphPad Software, Inc., La Jolla, USA). P values <0.05
were considered statistically significant.
Results
Phage isolation and morphology
PhageAP3was isolated in a water sample from irrigated fields
and propagated on the clinical B. cenocepacia 7780 strain,
examined by TEM, and morphologically classified as a
Caudovirales, Myoviridae member of the Peduovirinae sub-
family (Fig. 1). Its icosahedral head was estimated to be ap-
proximately 64 nm between opposite apices and connected to
a long-contractile 175-nm tail. The closely related phages
KS5, KS14, and KL3 have similarly sized capsids, each
65 nm in diameter; but in contrast, their tails vary in length,
140 nm for KS14, 150 nm for KS5, and 160 nm for KL3
(Lynch et al. 2010).
Genome analysis
The AP3 genome is 36,499 bp with a G + C content of
64.04 %. Nucleotide sequence comparison revealed that
AP3 is predicted to possess a 55-bp cohesive (cos) region,
conserved between the known cos regions of P2-like phages
(Supplementary Fig. S1). Cos regions in P2 and related
phages determine genome ends and are essential for transduc-
tion and phage packaging (Ziermann and Calendar 1990). As
Fig. 1 Transmission electron micrograph of AP3. The sample was
negatively stained with 2 % uranyl acetate and viewed at 80,000-fold
magnification. The size bar is 100 nm
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for P2-like Pseudomonas phage phiCTX (NC_003278.1), the
cos region of AP3 is in close proximity to its integrase, which
is a unique position. However, similarly to all of P2-related
phages, within the cos region of AP3, GC-rich 20-nt 5′-ex-
truding cohesive ends (5′ GGTGGGGCGGGGTCACAACT)
can be predicted. Analogous to the P2-related phages, the cos
site was set as the start (cosL; left cohesive end) and end
(cosR; right cohesive end) of the AP3 genome.
There are 51 predicted CDSs: 44 start with ATG codon
(Met), 6 start with GTG (Val), and 1 start with TTG (Leu).
The circular map of AP3 phage genome organization shows
clearly defined genome organization, with host interaction,
DNA metabolism and replication, structural, and lysis and
lysogeny coding genes (Fig. 2). This last region of genes also
comprises an interesting cytotoxic translational repressor of
toxin-antitoxin stability, which may be involved in an abortive
phage infection system (Labrie et al. 2010). Supplementary
Table S1 shows key annotation information including locus
tag, molecular data, and homologs with predicted protein mo-
tifs for all proteins. Also, the annotation uses the gene num-
bers corresponding to those assigned the Circos map (Fig. 2).
Four host promoters located in the intergenic regions of AP3
genome were predicted based on analysis of recurrent motifs
in the intergenic regions (Supplementary Table S2). Given
their specific location, it is likely that they cover transcription
of early, middle, and late genes. No conserved phage promoter
motifs could be identified during the analysis. A single factor-
independent terminator was predicted with transcription ter-
mination functions at the negative and positive strands. No
tRNA-coding sequence could be discerned in the AP3
genome.
Based on BLASTN, the AP3 nucleotide sequence
shows high homology to six other P2-like phages
(Supplementary Table S3). The related phage genome
lengths vary between 35,741 (φE202) and 40,555 bp
(KL3), as does the G + C content, ranging from 63.22
(KL3) to 68.82 % (BEK). The number of protein coding
sequences ranges between 45 (KS5) and 57 (BEK). An
interesting aspect, which was not noted previously, is the
distribution of the CDSs. Even though there are only rel-
atively small differences in the lengths of the genomes,
significant differences exist in the number of coding se-
quences. The most similar phage to AP3 was KS5, which
infects B. cenocepacia (Lynch et al. 2010). Phage KL3,
which has the largest genome among all compared
phages, has only two CDSs more than AP3, while the
∼3 kbp smaller phage BEK has seven more. Based on
the CoreGenes 3.5 output table, all phages share 31 ho-
mologous genes, 8 of which are hypothetical and 23 are
genes encoding proteins with a predicted function.
Fig. 2 Genome map of
Burkholderia phage AP3.
Structural protein genes (yellow),
lysis cassette (green), DNA
metabolism and replication (red),
host interaction protein genes
(blue), and hypothetical protein
genes (gray). Both terminators
and promoters are also noted on
the map
Appl Microbiol Biotechnol (2017) 101:1203–1216 1209
Figure 3 shows the genes of AP3 compared to other P2-like
phages along with the direction of their transcription.
Genomes were arranged with the most similar phages lying
adjacent to AP3, while the least similar phages are more dis-
tant. The comparison suggests that KS5 holds closest relation
to AP3 and φ52237 is least homologous. The KL3, φE202,
φX216, and φ52237 phages show a high level of nucleotide
similarity among each other but less to KS5 and AP3. Further
genome analysis indicated that despite BLASTN showing sig-
nificant similarity between seven selected BCC phages, the
annotation differed. Starting positions of AP3 vary for closely
related phages available in the database. In KS5, KL3, and
φ52237, all genes were annotated on the opposite strand in
comparison to AP3 genome. Genomes of BEK, φE202, and
φX216 are oriented according to the Enterobacteria phage
P2. None of the selected phages have predicted promoter
and terminator sequences in their GenBank files and the com-
parison of those elements was omitted in our analysis.
Lysis cassette
A closer inspection of the AP3 genome reveals a four-
component lysis cassette comprising a putative antiholin, pu-
tative holin, endolysin, and spanins, similar to the model de-
scribed in detail for λ, T4, and P2 phages (Berry et al. 2013;
Garrett et al. 1981; Morita et al. 2001; Moussa et al. 2012;
Summer et al. 2007a; To et al. 2013; White et al. 2011; Young
2014). In this model, the holin perforates the inner membrane
and forms non-specific channels required for the transport of
endolysin across the membrane. In AP3, the predicted holin
(AP3_0014) is a small-size protein (106 residues; 11.3 kDa)
with two hydrophobic transmembrane helices, classified as a
class II holin. The phage holin activity is regulated by the
antiholin, which prevents premature lysis (Ryan and
Rutenberg 2007). The predicted antiholin of AP3
(AP3_0013) is also a small protein (124 residues; 12.7 kDa)
that possesses two transmembrane domains. In the periplas-
mic space, the released endolysin destroys the peptidoglycan
bonds, leading to host lysis by the internal turgor pressure.
The AP3 endolysin (AP3_0015) is a modular protein (266
residues; 28.9 kDa) with two conserved domains: a putative
peptidoglycan binding domain PG_binding_1 and a
DUF3380 domain, which was recently associated with a
phage-mediated N-acetylmuramidase activity of a
Salmonella phage (Rodríguez-Rubio et al. 2016). The last part
of the system comprises a spanin (unimolecular or as a com-
plex). Spanin is anchored to both the inner and outer cell
membranes and causes the physical destruction of the outer
membrane. In AP3, the spanin moiety of the lysis cassette is
predicted to be a complex of two proteins i-spanin and o-
spanin encoded by separate genes: AP3_0016 and
AP3_0017, respectively. The AP3_0012 product is a predict-
ed integral membrane protein (162 residues, 17.1 kDa) with
one N-terminal transmembrane domain. The AP3_0013 gene,
encoding an outer membrane lipoprotein (66 residues,
7.0 kDa), overlaps the +1 frame within the i-spanin gene. A
comparative analysis of the lysis cassette was also performed
among AP3, the closely related phages KS5, KL3, φE202
φX216 , BEK, and φ52237 , and the re f e r ence
Enterobacteria P2 phage (Fig. 4). This analysis demonstrated
a closer relationship in the lysis cassettes of KL3, φE202
φX216, BEK, and φ52237 phages than in those of AP3 and
KS5, which are more similar to each other.
Microbiological analysis of Burkholderia phage AP3
AP3 forms small, clear plaques of about 1 mm diameter when
tested with the soft agar overlay method. In one-step growth
curves, the latent period was estimated around 60–65min, and
approximately 40–45 progeny virions are produced per infect-
ed host cell. The bacteriophage retains almost 100 % infectiv-
ity after incubation at pH 4–10 up to 5 h, whereas pH 2 re-
duces the phage titer completely after only 1 h of incubation.
Ten minutes exposure to 60 °C halves the pfu number, and
after 30 min, a 10-fold reduction was observed, while the
incubation for 10 min at 70 °C results in a decrease of five
orders of magnitude in phage titer. The AP3 virions are
completely destroyed after 30 and 10 min incubation at 70
and 80 °C, respectively. Stability tests show that AP3 is ex-
tremely sensitive to chloroform with a four-order reduction in
phage titer after 2 h exposure and no remaining infective par-
ticles after 24 h. This is consistent with some reports about
chloroform-sensitive tailed phages examined by our group
Fig. 3 Pairwise comparison using TBLASTX of the AP3 and six
selected BCC P2-like phages. Lines linking genomes represent high
pairwise similarity between phages. Putative phage specific promoter
sites (green lines), rho-independent terminator (red lines), and
percentage of similarity between similar regions (shade scale on the
bottom of the figure)
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and other researchers earlier (Kesik-Szeloch et al. 2013;
Ackermann 2006). Sixty-one BCC representative strains
(Table 1) were used for the AP3 host range assays:
B. cenocepacia (20 isolates), B. cepacia (1 isolate),
B. contaminans (5 isolates), B. multivorans (29 isolates),
B. seminalis (1 isolate), B. stabilis (2 isolates), and B.
vietnamiensis (3 isolates). AP3 was only able to propagate
on 10 of the 16 B. cenocepacia IIIA isolates. PFGE analysis
reveals differences in restriction patterns for each
B. cenocepacia IIIA isolate, indicating that the sensitive bac-
teria do not belong to the same clone (Supplementary Fig. S2).
As the specific recognition of bacterial receptor is the main
step of successful phage adsorption, a detailed in silico anal-
ysis of the tail fiber protein (TFP) was performed. Phages
infecting different species and sharing high homology of tail
fiber proteins are successful in cross-infecting their host
strains (Smith et al. 2007; Simpson et al. 2015). Phage tail
fiber protein (vB_BceM_AP3_0025) from phage AP3 was
compared to the NCBI protein database using BLASTP to
find its homologs occurring in different species. Eight hits
holding similarity of more than 70 % were investigated fur-
ther. One sequence belongs to Burkholderia phage ST79 (lytic
phage), while all other proteins are part of temperate bacterio-
phages genomes, integrated in bacterial genomes. These
strains include B. cenocepacia D2AES, B. cenocepacia
PT15, B. g lumae 3252-8 , B. g lad io l i UCD-UG
CHAPALOTE, B. glumae NCPPB 3923, B. glumae BGR1,
and B. glumaeLMG2196. Database records of these genomes
(except LMG 2196) have been generated using whole genome
shotgun (WGS) techniques and were not assembled into one
complete scaffold. Genes found in all eight strains hold strong
similarity in amino acid content (Supplementary Fig. S3). The
origin, location, and size of the homologous genes, as well as
precise level of their similarity (ranging between 72 and
82 %), are presented in Supplementary Table S4. From all
inspected genomes, B. glumae BGR1 tail fiber protein shows
the lowest homology to AP3 phage, whereas B. cenocepacia
D2AES was most similar. The latter gene product also has the
approximate number of amino acids (1114 aa) as the AP3
phage (1113 aa). As expected, the highest homology scores
could be observed among temperate phages whose hosts be-
long to B. cenocepacia group. Similar comparison of tail fiber
protein was conducted between phage AP3 and closely related
Burkholderia phages KS5, KL3, φE202, BEK, φX216, and
φ52237 (Supplementary Fig. S4). The comparison via
ClustalOmega (Goujon et al. 2010; Sievers et al. 2011) shows
high similarity on the N-terminus part of TFP which serves as
connector to the phage structural proteins and dropping sig-
nificantly while moving to the C-terminus direction which is
responsible for host receptor recognition and binding
Fig. 4 The organization of the
lysis cassette of Enterobacteria
P2 and selected BCC P2-like
viruses
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(Simpson et al. 2015). Interestingly, the AP3 phage TFP is
twice as long as any other protein compared, having additional
365 aa at C-terminal end. A smaller difference in length might
be observed between AP3 and KL3 phage, as there is an
additional 97 aa region for KL3. All phages are highly similar
on the N-terminal ∼170 aa, after which similarity level drops.
At the C-terminal end (after 740 aa), AP3 phage TFP is unique
and does not resemble any of the compared bacteria or phages.
Galleria infection treatment assay and the emergence
of phage-resistant mutants
The wax moth larvae model was used to evaluate in vivo the
antibacterial efficacy of AP3 temperate phage in the eradica-
tion of B. cenocepacia 7780 infection. Larvae were inoculated
with the LD50 dose of 10
5 cells per larvae followed by the
injection of AP3 phage within 30 min post-infection at the
MOI of 10 (Fig. 5). The negative controls (uninfected larvae
and larvae phage lysate treated; N = 30 each probe) show a
100 % survival rate. The survival of BCC infected larvae was
80, 60, and 0 % after 18, 24, and 48 h post-injection, respec-
tively. In contrast, AP3 phage application significantly ex-
tends larvae survival (P < 0.0001) to 95, 72, 30, and 15 %
surviving larvae after 18, 24, 48, and 72 h post-infection,
respectively.
Phage treatment results in the emergence of phage-resistant
variants. We therefore analyzed the emergence of AP3-
resistant variants at 24 h after infection in broth culture
(Table 2). From 20 randomly chosen colonies, four (M1-3 to
M1-6) remain susceptible to AP3 phage infection, while the
rest of the 16 clones became resistant to AP3. PCR analysis
was used to assess whether the resistance depends on the
integration of the AP3 genome in the bacterial chromosome.
The integration site of AP3 was initially based on sequence
similarity to other P2-like Burkholderia phages which encode
integrase and was confirmed experimentally. Two integration
sites were previously described for BCC phages—tRNA
genes and AMP nucleosidases (Lynch et al. 2010; Ronnig
et al. 2010). The latter one was thought to be less probable,
due to the high similarity of AP3 to KL3,φ52237, andφE202
viruses, which all integrate in tRNA genes (either tRNA[Thr]
or tRNA[Phe]). This was further confirmed using PHAST
(Zhou et al. 2011), which predicts a similar phage integrated
at the end of a B. cenocepacia MC0-3 chromosome 1
(CP000958) tRNA, with the attP site in downstream of the
integrase. During the recombination of attP and attB, the
integrase splits into two fragments substituting last 33 nucle-
otides (located on its 3′ end) with last 15 nucleotides of bac-
terial tRNA-Arg (also located on 3′ end; Fig. 6). This process
does not influence the functionality of the bacterial tRNA-
Arg, which is produced even after phage integration. The ac-
quisition of AP3 phage was confirmed by the presence of a
gene encoding a translational repressor of a toxin-antitoxin
stability system. All 16 resistant bacterial variants were posi-
tive for this unique AP3 gene and similarly for the intact
integrase gene, indicating the episomal state of the phage.
The phage integration site next to the bacterial tRNA gene
was confirmed for 10 of the 16 isolates (Table 2). All resistant
variants were as virulent as the parental strain in the Galleria,
indicating that AP3 lysogeny had no significant effect in
B. cenocepacia pathogenicity.
Discussion
In this manuscript, we report the isolation and characterization
of the Burkholderia phage vB_BceM_AP3 (AP3), a member
of the P2likevirus genus, as a potential antibacterial agent.
AP3 exhibits high pairwise nucleotide identity (61.7 %) to
another B. cenocepacia infecting phage KS5 and lower ho-
mology (46.7–49.5 %) to the remaining P2likevirus phages
specific to Burkholderia species. The similarities between
AP3 and compared temperate phages (KL3, φ52237, and
φE202) can be seen in terms of integration site found as
tRNA (either tRNA[Thr] or tRNA[Phe]; Zhou et al. 2011),
with the attP site downstream of phage integrase sequence
homologous to the end of bacterial tRNA gene; thus, host
gene disruption is unlikely (Fig. 6). Further comparison of
Fig. 5 Antibacterial activity of
AP3 phage (MOI 10) in the
treatment of B. cenocepacia
7780-infected Galleria larvae.
Statistical analysis was calculated
for pairwise comparisons between
infected larvae and phage-treated
infected larvae using Mantel–Cox
test (denoted P values <0.05).
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Table 2 B. cenocepacia 7780 variants isolated from the culture after AP3 phage propagation
No. Bacteria AP3 phage activity Unique gene
presence
Integrase gene
presence
Integration next
to tRNA gene
LD50 per
Galleria larvae
[N = 20]10^5 pfu/ml 10^7 pfu/ml
1 Wild type 7780 + + − − − 10^5
2 M1-1 − − + + − 10^5
3 M1-2 − − + + − 10^5
4 M1-3 + + − − − 10^5
5 M1-4 + + − − − 10^5
6 M1-5 + + − − − 10^5
7 M1-6 + + − − − 10^5
8 M1-7 − − + + − 10^5
9 M1-8 − − + + + 10^5
10 M1-9 − − + + − 10^5
11 M1-10 − − + + + 10^5
12 M2-6 − − + + + 10^5
13 M2-7 − − + + − 10^5
14 M2-8 − − + + + 10^5
15 M2-9 − − + + + 10^5
16 M2-10 − − + + − 10^5
17 M3-6 − − + + + 10^5
18 M3-7 − − + + + 10^5
19 M3-8 − − + + + 10^5
20 M3-9 − − + + + 10^5
21 M3-10 − − + + + 10^5
+ active, − no activity, M isolated clone after phage treatment
Fig. 6 The scheme of AP3 phage integration site
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P2likevirus BCC phages reveals a conserved organization of
the lysis cassette (putative antiholin, putative holin, endolysin,
and spanins) and show a >86 % homology between AP3 and
KS5 specific lysis genes. Therefore, we conclude these tem-
perate phages share a conserved lysogenization and lysis strat-
egy. Considering phage application as an antimicrobial agent,
it is important to choose phages with a wide host range for
more effective use against different clinical isolates (Abedon
2011; Drulis-Kawa et al. 2012). The crucial step of successful
phage infection is the ability of specific host receptor recog-
nition conditioned mostly by TFP. The AP3 temperate phage
described here is specific to B. cenocepacia lineage IIIA
strains and can propagate on 10 out of 18 multidrug-resistant
clinical strains. The TFP amino acids sequence comparison
revealed that AP3 phage probably recognizes another bacteri-
al receptor than the other P2likevirus representatives and it is
the first isolated and sequenced Burkholderia phage from this
genus highly similar to prophages found in Burkholderia sp.
genomes.
AP3 was very effective to eradicate B. cenocepacia 7780
infection inG. mellonella larvae. At the relatively lowMOI of
10, AP3 was able to significantly (P < 0.0001) increase the
survival rate of infected larvae even after 72 h post-infection.
This is similar to the results obtained for lytic Pseudomonas
phages (MOI = 100) examined by us previously (Olszak et al.
2015; Danis-Wlodarczyk et al. 2016). The application of tem-
perate phages might result in possible undesirable conse-
quences related to phage integration and potential increase in
host virulence (Young and Gill 2015). However, a detailed
analysis of phage AP3 genome against the database confirmed
lack of toxin sequences, similarly to previous report about
Burkholderia phages (Summer et al. 2007b). Furthermore,
isolated phage-resistant clones were positive for AP3 genome
acquisition as prophage or episome form of phage, and they
showed no significant increase in bacterial pathogenicity com-
pared to the parental strain in theG. mellonella infection mod-
el. AP3-integrated strains remained constant so virulence
seems to be neither positively nor negatively affected. This
agrees with previous reports (Summer et al. 2007a, b;
Ronning et al. 2010) indicating there is no experimental evi-
dence that Burkholderia virulence determinants arise from
phage origin, except drug resistance to particular antibiotics.
However, it is possible that the Burkholderia species collect
prophages and prophage-like elements to acquire genes
benefiting their survival in soil and rhizosphere environment
(Summer et al. 2007a, b; Ronning et al. 2010). In general, the
temperate phages condition horizontal dissemination of genes
(HGT) by transduction and then phage conversion. It should
be emphasized that lytic phages and bactericidal antibiotics
are responsible for HGT as well by lysis product release as
DNA fragments and indirectly by induction of temperate
phages (Weinbauer 2004). Of course, the in vivo efficacy of
these phages would need to be established. A major
consideration is that the CF lung environment has a dynamic
microbiome and it is not possible to predict the possible im-
pact of each phage protein that could be an effector of BCC
fitness in the lung. Nevertheless, our results show good lytic
activity of the temperate AP3 phage with no evidence of in-
creased virulence in lysogenic isolates in caterpillar model,
suggesting that this phage is a potent lead against bacterial
strains belonging to B. cenocepacia IIIA lineage, which are
commonly isolated from CF patients.
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